Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,450 total articles
Nano-X Imaging Ltd announced its financial results for Q1 2026, reporting increased revenue driven by teleradiology services and initial commercial use of its Nanox.ARC imaging systems. The company reaffirmed progress in deployments and partnerships, including integration at a RadNet facility in the U.S. Despite improved revenue, Nano-X incurred a …
Willis Lease Finance Corporation has acquired three Airbus A330-300 aircraft that will be leased to China Airlines and EVA Air. This strategic purchase aims to capitalize on strong demand for aviation assets amid fleet growth and maintenance capacity constraints, further expanding Willis Lease's portfolio and reinforcing its global aviation service…
TransUnion releases a comprehensive report forecasting how a 25 basis-point change in mortgage rates from 6.5% could reshape the pool of mortgage-ready renters across U.S. metropolitan areas, influencing local housing demand and supply dynamics. The report segments markets by sensitivity to rate changes, providing actionable insights to real estate…
OptimizeRx Corp. announced the launch of its patent-pending Natural Language Audience Builder (NLAB), an AI-driven tool designed for integration within demand-side platforms (DSPs) and agency media planning platforms. NLAB allows life sciences marketers to build and refine custom healthcare provider audiences using real-world evidence and proprieta…
BriaCell Therapeutics has entered into a memorandum of understanding with Uneedle to support commercial readiness and scaling of Uneedle's microneedle technology for the intradermal administration of Bria-IMT, BriaCell's lead Phase 3 immunotherapy candidate for metastatic breast cancer. This technology is currently used in BriaCell's pivotal Phase …
Plus Therapeutics' subsidiary CNSide Diagnostics has signed a national coverage agreement with Elevance Health to provide the CNSide® Cerebrospinal Fluid Tumor Cell Enumeration assay, expanding coverage to approximately 126 million people in the U.S. The CNSide® assay aids rapid diagnosis and treatment monitoring for patients with leptomeningeal me…
Prairie Operating Co., a Nasdaq-listed independent energy company focused on oil and natural gas development in the Denver-Julesburg Basin, announced key leadership changes with Gregory S. Patton appointed as CEO and Michael J. Shelly as CFO. These appointments aim to support the company's next growth phase, optimize capital structure, and enhance …
Kustom Entertainment, Inc. announces a binding agreement to divest its video solutions segment to Cycurion, Inc. The transaction includes $5.5 million plus 2 million warrants, enabling Kustom to focus on its growing live event production and ticketing business. This aligns with its recent rebranding and partnership with Gilley's Park City, position…
Vivani Medical has obtained regulatory approval from an Australian human research ethics committee to initiate its Phase 1 clinical trial, SLIM-1, testing the NPM-139 semaglutide implant designed for obesity and chronic weight management. This implant aims to improve medication adherence by providing a steady drug delivery over an extended period. …
VCI Global Limited announces that Esousa Group Holdings LLC, a New York-based institutional investor, converted warrants into 880,000 shares of common stock at a 24.9% premium to the previous closing price. This conversion underscores institutional confidence in VCI Global's AI-native platform strategy and strengthens the company's equity capital s…
RenX Enterprises Corp. announced a revised timeline for the delivery of its Microtec UTM 1200 Turbo Mill, now expected to arrive in the U.S. in Q3 2026 due to spare parts lead time and customs delays. Meanwhile, site preparations at the Myakka City, Florida facility are underway to support installation. This mill is pivotal to RenX's first-phase pr…
NuCube Energy, an advanced nuclear technology firm developing solid-state microreactors, has agreed to a business combination with Launch Two Acquisition Corp. (NASDAQ: LPBB), bringing NuCube to the public markets with an estimated valuation of $500 million pre-money. NuCube's NuSun™ microreactor technology delivers firm carbon-free power and high-…
Digital Currency X Technology Inc. announced a $700 million private placement of units payable in U.S. dollars or digital assets, marking a strategic shift from electric vehicle manufacturing to focus on digital asset treasury management and AI cloud computing services. The financing structure aligns with its digital asset holdings, allowing direct…
Flash Sports & Media, Inc. (Nasdaq: FLZH), a cricket-focused sports and media company, announced plans to launch the Zimbabwe T20 League (ZT20), a professional franchise-based T20 cricket league tentatively scheduled for October-November 2026. The league aims to showcase Zimbabwe as a premier cricket and sports-tourism destination, featuring matche…
Autolus Therapeutics plc announced its participation in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference, with CEO Dr. Christian Itin presenting a Fireside Chat to discuss the company's next-generation programmed T cell therapies. The event webcast will be accessible online and archived for 90 days.
Atea Pharmaceuticals has completed patient enrollment in its Phase 3 C-FORWARD trial evaluating the bemnifosbuvir and ruzasvir combination for hepatitis C treatment outside North America. This milestone advances Atea's global clinical program alongside the ongoing North American C-BEYOND trial, with topline results expected around year-end 2026, po…
Kymera Therapeutics announced early completion of enrollment in its Phase 2b BROADEN2 clinical trial for KT-621, an oral STAT6 degrader targeting moderate to severe atopic dermatitis. This accelerated enrollment allows for topline data readout by year-end 2026, six months ahead of schedule, and plans to initiate Phase 3 trials by mid-2027. KT-621 i…
Baker Hughes has been awarded a contract by Azule Energy to supply advanced subsea production systems, including deepwater horizontal tree systems and control modules, to support efficient oil production in Angola's ultra-deepwater Greater PAJ development. The company will leverage its local Angolan facilities and supply chain to optimize installat…
Satellos Bioscience Inc. announced new data from its SAT-3247 clinical development program will be featured at the 19th International Congress on Neuromuscular Diseases (ICNMD). The data includes six-month follow-up results from Phase 1b participants and ongoing Phase 2 trial updates. SAT-3247 is an investigational oral therapy aimed at regeneratin…
Lightbridge Corporation announced the successful removal of the first batch of its fuel material samples from irradiation testing at INL's Advanced Test Reactor. The samples will now undergo post-irradiation examination, providing critical data to support Lightbridge's nuclear fuel performance modeling, regulatory licensing, and commercial deployme…
Winnebago Industries announced its third quarter fiscal 2026 results with net revenues of $698.7 million, down 9.9% year-over-year driven by lower unit volumes, despite growth in the Motorhome RV segment. Adjusted EPS declined to $0.66 from $0.81 the prior year, reflecting industry headwinds including elevated fuel costs and weak consumer confidenc…
INmune Bio Inc. announced that the UK Medicines & Healthcare products Regulatory Agency (MHRA) approved the Pediatric Investigation Plan (PIP) for Ebstrocel™, part of the CORDStrom™ platform, targeting Recessive Dystrophic Epidermolysis Bullosa (RDEB). This regulatory milestone accelerates the path toward Marketing Authorization in the UK, aligning…
Montauk Brewing Co., a craft beer brand under Tilray Brands, Inc., marks its 14th anniversary with a special celebration at its Brew Barn in Montauk, NY. Events include the release of a limited Jalapeño Watermelon Ale, a community beach cleanup, a surfboard raffle benefiting the Surfrider Foundation, local food offerings, and live summer soccer cov…
Seres Therapeutics announced an upcoming webcast to present top-line data from an investigator-sponsored trial evaluating their live biotherapeutic SER-155 for immune checkpoint inhibitor-related enterocolitis (irEC), a severe side effect of cancer immunotherapy. The trial, conducted at Memorial Sloan Kettering Cancer Center, aims to show SER-155's…
Highlander Silver Corp. reported results from a detailed geophysical program at its Corani Silver Project, revealing a significantly larger mineral system concealed beneath shallow cover. The company identified several high-priority exploration targets and has commenced the first drilling program in over a decade, with initial assays expected soon.…
